Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Post-Translational Modifications of BRD4: Therapeutic Targets for Tumor
Na Liu, Rui Ling, Xiang Tang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Targeted protein degradation directly engaging lysosomes or proteasomes
Jiseong Kim, Insuk Byun, Do Young Kim, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 7, pp. 3253-3272
Open Access | Times Cited: 24
Triazole-fused pyrimidines in target-based anticancer drug discovery
Xing‐Jie Dai, Lei-Peng Xue, Shi‐Kun Ji, et al.
European Journal of Medicinal Chemistry (2023) Vol. 249, pp. 115101-115101
Closed Access | Times Cited: 31
Targeted Protein O-GlcNAcylation Using Bifunctional Small Molecules
Bowen Ma, Khadija Shahed Khan, Tongyang Xu, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 14, pp. 9779-9789
Open Access | Times Cited: 13
PROTACs targeting androgen receptor signaling: Potential therapeutic agents for castration-resistant prostate cancer
Yulu Zhang, Annan Ming, Junyan Wang, et al.
Pharmacological Research (2024) Vol. 205, pp. 107234-107234
Open Access | Times Cited: 8
A Minireview on BET Inhibitors: Beyond Bromodomain Targeting
Mikhail Iudin, Yu. M. Khodarovich, Anna M. Varizhuk, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 594-594
Open Access
USP22/BRD4 mediated hedgehog pathway activation contributes to airway remodeling in asthma
Huan Chen, Jing Liu, Jia Zhang, et al.
International Immunopharmacology (2025) Vol. 153, pp. 114538-114538
Open Access
Targeting BRD4: Potential therapeutic strategy for head and neck squamous cell carcinoma (Review)
Voraporn Yongprayoon, Napasporn Wattanakul, Winnada Khomate, et al.
Oncology Reports (2024) Vol. 51, Iss. 6
Open Access | Times Cited: 3
The epigenetic regulatory effect of histone acetylation and deacetylation on skeletal muscle metabolism-a review
Junjie Xu, Chenglong Li, Xiaolong Kang
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 8
The P53–P21–RB1 pathway promotes BRD4 degradation in liver cancer through USP1
Neng Li, Erlei Zhang, Zhenyong Li, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 3, pp. 105707-105707
Open Access | Times Cited: 2
Elevating PLK1 overcomes BETi resistance in prostate cancer via triggering BRD4 phosphorylation-dependent degradation in mitosis
Yanquan Zhang, Ka-wing Fong, Fengyi Mao, et al.
Cell Reports (2024) Vol. 43, Iss. 7, pp. 114431-114431
Open Access | Times Cited: 2
Systematic analysis of the BET family in adrenocortical carcinoma: The expression, prognosis, gene regulation network, and regulation targets
Yongli Situ, Quanyan Liang, Ziying Zeng, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 6
Lysine-specific demethylase 7A (KDM7A): A potential target for disease therapy
Changyun Li, Y. Liu, Tao Fan, et al.
Biochemical Pharmacology (2023) Vol. 216, pp. 115799-115799
Closed Access | Times Cited: 6
Proteome-wide analysis of lysine β-hydroxybutyrylation in the myocardium of diabetic rat model with cardiomyopathy
Weiguang Luo, Mei He, Qizhi Luo, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 9
Open Access | Times Cited: 5
Emerging Role of Plant-Based Dietary Components in Post-Translational Modifications Associated with Colorectal Cancer
Carmen Rodríguez‐García, Francisco Gutiérrez-Santiago
Life (2023) Vol. 13, Iss. 2, pp. 264-264
Open Access | Times Cited: 5
Increased expression of BRD4 isoforms long (BRD4-L) and short (BRD4-S) promotes chemotherapy resistance in high-grade serous ovarian carcinoma
Drumond-Bock Ana Luiza, Luyao Wang, Lin Wang, et al.
Genes & Cancer (2023) Vol. 14, pp. 56-76
Open Access | Times Cited: 4
A Review of the Bromodomain and Extraterminal Domain Epigenetic Reader Proteins: Function on Virus Infection and Cancer
Mengli Wu, Guiquan Guan, Hong Yin, et al.
Viruses (2024) Vol. 16, Iss. 7, pp. 1096-1096
Open Access | Times Cited: 1
The role of protein post-translational modifications in prostate cancer
Yinghui Hao, Chenqiong Gu, Wenfeng Luo, et al.
PeerJ (2024) Vol. 12, pp. e17768-e17768
Open Access | Times Cited: 1
BRD4 promotes immune escape of glioma cells by upregulating PD-L1 expression
Yongsheng Liu, Lize Cai, Hao Wang, et al.
Journal of Neuro-Oncology (2024) Vol. 171, Iss. 3, pp. 669-679
Closed Access | Times Cited: 1
Therapeutic approaches targeting oncogenic proteins in myeloid leukemia: challenges and perspectives
Xing Yan, Yuan Yuan Kang, Ze Yan Zhang, et al.
Expert Opinion on Therapeutic Targets (2024)
Closed Access | Times Cited: 1
Angiogenesis in gastrointestinal stromal tumors: From bench to bedside
Stavros P. Papadakos, Christos Tsagkaris, Marios Papadakis, et al.
World Journal of Gastrointestinal Oncology (2022) Vol. 14, Iss. 8, pp. 1469-1477
Open Access | Times Cited: 7
Advances in research on potential inhibitors of multiple myeloma
Tang Guoyuan, Shan Huang, Ji Luo, et al.
European Journal of Medicinal Chemistry (2023) Vol. 262, pp. 115875-115875
Closed Access | Times Cited: 3
Lysine deserts and cullin-RING ligase receptors: Navigating untrodden paths in proteostasis
Natalia A. Szulc, Małgorzata Piechota, Lilla Biriczová, et al.
iScience (2023) Vol. 26, Iss. 11, pp. 108344-108344
Open Access | Times Cited: 3
Review on: BRD4 inhibitors for anticancer research
Vindhya Vikram Singh, Shafqat Alauddin
Human Gene (2023) Vol. 37, pp. 201196-201196
Closed Access | Times Cited: 3
Epigenetic Reader Bromodomain-Containing Protein 4 in Aging-Related Vascular Pathologies and Diseases: Molecular Basis, Functional Relevance, and Clinical Potential
Xiaoxu Zheng, Kotryna Diktonaite, Hongyu Qiu
Biomolecules (2023) Vol. 13, Iss. 7, pp. 1135-1135
Open Access | Times Cited: 3
AP-2δ Is the Most Relevant Target of AP-2 Family-Focused Cancer Therapy and Affects Genome Organization
Damian Kołat, Lin-Yong Zhao, Mateusz Kciuk, et al.
Cells (2022) Vol. 11, Iss. 24, pp. 4124-4124
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top